Variant report
Variant | nsv524029 |
---|---|
Chromosome Location | chr3:118154526-118157095 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4688104 | chr3:118154526-118154527 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs4688105 | chr3:118154533-118154534 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs181109119 | chr3:118154557-118154558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546816752 | chr3:118154566-118154567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114517649 | chr3:118154587-118154588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551437962 | chr3:118154641-118154642 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538910688 | chr3:118154862-118154863 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557236411 | chr3:118154892-118154893 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575233153 | chr3:118154914-118154915 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553070 | chr3:118154937-118154938 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs186342390 | chr3:118154996-118154997 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190802664 | chr3:118155058-118155059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540743378 | chr3:118155105-118155106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565039408 | chr3:118155139-118155140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182982155 | chr3:118155167-118155168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186526553 | chr3:118155231-118155232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562817384 | chr3:118155235-118155236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566574 | chr3:118155276-118155277 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547908467 | chr3:118155280-118155281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190920679 | chr3:118155290-118155291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575549693 | chr3:118155310-118155311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1447592 | chr3:118155333-118155334 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs545130482 | chr3:118155335-118155336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571461725 | chr3:118155339-118155340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532615920 | chr3:118155361-118155362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182631241 | chr3:118155408-118155409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569486576 | chr3:118155409-118155410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs536627279 | chr3:118155411-118155412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148885133 | chr3:118155440-118155441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72969533 | chr3:118155456-118155457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs187710635 | chr3:118155496-118155497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192710856 | chr3:118155513-118155514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115698515 | chr3:118155552-118155553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572160575 | chr3:118155575-118155576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375141698 | chr3:118155592-118155593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183444262 | chr3:118155651-118155652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559095401 | chr3:118155657-118155658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577108126 | chr3:118155696-118155697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143485189 | chr3:118155709-118155710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541190757 | chr3:118155717-118155718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556481540 | chr3:118155809-118155810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186967217 | chr3:118155843-118155844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192228259 | chr3:118155849-118155850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184249625 | chr3:118155879-118155880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527289910 | chr3:118155912-118155913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78941473 | chr3:118155915-118155916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576749294 | chr3:118155945-118155946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560894954 | chr3:118156006-118156007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140200068 | chr3:118156018-118156019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs76972243 | chr3:118156019-118156020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Characteristic facial feature | 22180640 | CNVD |
hypoplastic male genitals | 22180640 | CNVD |
postnatal overgrowth | 22180640 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Cancer | 21272361 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:118154200-118154600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:118154600-118155000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr3:118155000-118156400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |